دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion
Cesar R. Zoni MD, Debabrata Mukherjee MD, MS, Martha Gulati MD, MS
doi : 10.1002/ccd.30667
Relationship between coronary volume, myocardial mass, and post-PCI fractional flow reserve
Niya Mileva MD, Hirofumi Ohashi MD, PhD, Pasquale Paolisso MD, Jonathon Leipsic MD, PhD, Takuya Mizukami MD, PhD, Jeroen Sonck MD, PhD, Bjarne L. Norgaard MD, PhD, Hiromasa Otake MD, PhD, Brian Ko MD, PhD, Michael Maeng MD, PhD, Daniel Munhoz MD, PhD, Sakura Nagumo MD, PhD, Marta Belmonte MD, Dobrin Vassilev MD, PhD, Daniele Andreini MD, PhD, Emanuele Barbato MD, PhD, Bon-Kwon Koo MD, PhD, Bernard De Bruyne MD, PhD, Carlos Collet MD, PhD
doi : 10.1002/ccd.30664
Fractional flow reserve (FFR) measured after percutaneous coronary intervention (PCI) carries prognostic information. Yet, myocardial mass subtended by a stenosis influences FFR. We hypothesized that a smaller coronary lumen volume and a large myocardial mass might be associated with lower post-PCI FFR.
The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions
Pooja S. Yesantharao MD, Eric W. Etchill MD, MPH, Alice L. Zhou MS, Chin Siang Ong MBBS, PhD, Thomas S. Metkus MD, Joseph K. Canner MHS, Diane E. Alejo BS, Oluseyi Aliu MD, MS, Matthew J. Czarny MD, Rani K. Hasan MD, Jon R. Resar MD, Stefano Schena MD, PhD
doi : 10.1002/ccd.30670
Transcatheter aortic valve replacement (TAVR) is an increasingly used but relatively expensive procedure with substantial associated readmission rates. It is unknown how cost-constrictive payment reform measures, such as Maryland's All Payer Model, impact TAVR utilization given its relative expense.
Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies
Michel Pompeu Sá MD, MSc, MHBA, PhD, Jef Van den Eynde BSc, Xander Jacquemyn BSc, Ozgun Erten MD, Roberto Rodriguez MD, MSc, Scott Goldman MD, Paul M. Coady MD, Eric Gnall DO, William A. Gray MD, Harish Jarrett MD, Sandra V. Abramson MD, Marie-Annick Clavel DVM, PhD, Philippe Pibarot DVM, PhD, Basel Ramlawi MD, FRCSC
doi : 10.1002/ccd.30666
Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is associated with higher risk of mortality and rehospitalization for heart failure. Efforts to prevent conduction abnormalities (CA) requiring PPI after TAVI should be made. The membranous septum (MS) length and its interaction with implantation depth (ID–�MSID) could provide useful information about the risk of CA/PPI following TAVI.
Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation
Jose M. De la Torre Hernandez MD, PhD, Gabriela Veiga Fernandez MD, Sergio Barrera MD, Fermin Sainz Laso MD, Dae-Hyun Lee MD, Cristina Ruisanchez Villar MD, PhD, Piedad Lerena MD, Tamara Garcia Camarero MD, Jose M. Cuesta Cosgaya MD, Aritz Gil Ongay MD, Javier Zueco MD
doi : 10.1002/ccd.30673
We sought to investigate the effect of a 15-min delayed intraprocedural reassessment of paravalvular aortic regurgitation (PVR) after an immediate evaluation of posttranscatheter aortic valve replacement (TAVR) on the regurgitation grading and usage of postdilatation.
Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion
Motahar Hosseini MD, Brian D. Lahr MS, Kevin L. Greason MD, Arman Arghami MD, MPH, Rajiv Gulati MD, PhD, Mackram F. Eleid MD, Juan A. Crestanello MD
doi : 10.1002/ccd.30658
Obesity has been associated with an increased risk of vascular complication during percutaneous coronary intervention, but there are no data on the risk of vascular complication during percutaneous transfemoral transcatheter aortic valve insertion (TAVI).
CTO revascularization in TAVR patients�The jury is still out
Ashish Pershad MD, MS
doi : 10.1002/ccd.30663
Left atrial appendage occlusion using hydrogel coils in a child
Bassel Mohammad Nijres MD, MS, Benjamin Reinking MD, Osamah Aldoss MD
doi : 10.1002/ccd.30657
Left atrial appendage occlusion in young children has not been reported before. Herein, we describe a successful occlusion using hydrogel coils in a toddler. The decision to occlude the appendage was made to mitigate the potential risk of systemic thromboembolism, given the child's unusual anatomy.
Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series
Ilan Merdler MD, MHA, Nelson L. Bernardo MD, PhD, Itsik Ben-Dor MD, Ron Waksman MD
doi : 10.1002/ccd.30668
Suture-based vascular closure devices have been shown to be effective in hemostasis for procedures with vascular access. However, iatrogenic vascular occlusion may occur. The cutting balloon (CB) is a noncompliant balloon wrapped with 3–4 microsurgical blades that are intended to modify vascular lesions, but it may also be utilized to cut and release endovascular sutures.
Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study
Aaysha Cader MD, Mirvat Alasnag FACP, FSCAI
doi : 10.1002/ccd.30672
A tale of two ASDs�Compliance matters
Athar M. Qureshi MD, Srinath T. Gowda MD
doi : 10.1002/ccd.30669
Peripheral vascular disease interventions: One size does not fit all
Mahin R. Khan MD, Hani Jneid MD, FAHA, FSCAI
doi : 10.1002/ccd.30671
Refining the NobleStitch PFO closure technique using an anatomy-tailored approach
Marie-France Poulin MD, Clifford J. Kavinsky MD, PhD
doi : 10.1002/ccd.30661
